Best Peptides for Weight Loss
GLP-1 agonists and metabolic peptides studied for weight management and fat loss
Weight loss peptides — particularly GLP-1 receptor agonists like Semaglutide and Tirzepatide — have become the most commercially significant peptide class in recent years. These compounds work by mimicking incretin hormones that regulate appetite, blood sugar, and metabolic rate.
The metabolic peptides listed below range from FDA-approved medications to experimental research compounds. We present the evidence objectively: what the clinical trials actually show, what the dosing protocols look like, and what side effects have been documented.
Weight Loss Peptides (7)
Semaglutide
Semaglutide is a medication that mimics a natural fullness hormone (GLP-1) in the body. It is FDA-approved as Wegovy for weight management and Ozempic for type 2 diabetes, with significant effects on appetite control and blood sugar regulation.
Tirzepatide
Tirzepatide is a dual-action medication that activates both GIP and GLP-1 receptors, two key fullness and blood sugar hormones. It is FDA-approved as Mounjaro for type 2 diabetes and Zepbound for weight management, outperforming semaglutide in head-to-head trials.
Retatrutide
Retatrutide is an investigational medication that activates three hormone receptors (GIP, GLP-1, and glucagon) at the same time. Phase 2 trials showed up to 24% body weight loss at 48 weeks, and it is currently in Phase 3 development.
Liraglutide
Liraglutide is a medication that mimics a natural fullness hormone (GLP-1) in the body. It is FDA-approved as Victoza for type 2 diabetes and Saxenda for weight management, with an extensive record of clinical safety and effectiveness data.
5-Amino-1MQ
5-Amino-1MQ is a small molecule that blocks an enzyme linked to fat storage and metabolic problems. Research focuses on fat cell metabolism, weight loss, and reversing diet-related obesity in animal studies.
HGH Fragment 176-191
HGH Fragment 176-191 is a stabilized piece of human growth hormone (amino acids 176-191) and the parent compound of AOD-9604. Research focuses on fat breakdown without the growth-promoting or blood sugar effects of full growth hormone.
AOD-9604
AOD-9604 is a modified fragment of human growth hormone (amino acids 176-191). Originally developed as an anti-obesity compound, it shows preclinical evidence for promoting fat metabolism without affecting blood sugar or growth.
Frequently Asked Questions
What is the most effective weight loss peptide?
Based on clinical trial data, Tirzepatide (a dual GIP/GLP-1 agonist) has shown the largest average weight loss in Phase 3 trials — up to 22.5% body weight reduction at the highest dose. Semaglutide 2.4mg (Wegovy) showed approximately 15% average weight loss. Retatrutide (a triple agonist) showed up to 24% in Phase 2 trials.
Are weight loss peptides FDA approved?
Semaglutide (as Wegovy/Ozempic) and Tirzepatide (as Mounjaro/Zepbound) are FDA-approved for weight management or type 2 diabetes. Other metabolic peptides like AOD-9604, Retatrutide, and 5-Amino-1MQ are not FDA-approved and remain in research stages.
How do GLP-1 peptides cause weight loss?
GLP-1 receptor agonists reduce appetite by acting on brain regions that control hunger and satiety, slow gastric emptying (making you feel full longer), and improve insulin sensitivity. Dual and triple agonists like Tirzepatide and Retatrutide add GIP and/or glucagon receptor activation for additional metabolic effects.